サマリー

腎性貧血治療薬の世界市場 2024-2028
腎性貧血治療薬市場は2023〜2028年に20億8000万米ドル成長し、予測期間中のCAGRは7.59%で加速すると予測されます。この調査レポートは、腎性貧血治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。腎性貧血市場は、大規模なCKD患者の存在、高齢者人口の増加、腎性貧血治療薬の新薬承認などが市場を牽引しています。
Technavioの腎性貧血治療薬市場は以下のように区分されています：
タイプ別
- 点滴
- 経口剤
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の腎性貧血治療薬市場の成長を促進する主な要因の1つとして、バイオシミラーの採用拡大が挙げられます。また、腎臓内科における個別化医療や精密医療の重視の高まりや、パイプラインにある腎性貧血治療薬の数の増加は、市場の大きな需要につながるでしょう。
当レポートでは、腎性貧血治療薬市場について以下の領域をカバーしています：
- 腎性貧血治療薬市場のサイジング
- 腎性貧血治療薬市場予測
- 腎性貧血治療薬市場の産業分析
本レポートでは、腎性貧血治療薬市場の主要ベンダーであるAkebia Therapeutics Inc.社、Amgen Inc.社、AstraZeneca Plc社、Bayer AG社、Covis Pharma GmbH社、CSL Ltd.社、第一三共株式会社、Dr. Reddys Labordys Inc.アムジェン社、アストラゼネカ社、バイエル社、コヴィスファーマ社、CSL社、第一三共社、ドクター・レディーズ・ラボラトリーズ社、F.ホフマン・ラ・ロシュ社、ファイブロジェン社、グラクソ・スミスクライン社、日本たばこ産業社、JCRファーマケミカルズ社、キリンホールディングス社キリンホールディングスLtd.、三菱化学グループ、Pfizer Inc.、Pharmacosmos AS、Sun Pharmaceutical Industries Ltd.、Travere Therapeutics Inc.、Astellas Pharma Inc.などである。また、腎性貧血治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/renal-anemia-therapeutics-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global renal anemia therapeutics market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global renal anemia therapeutics market 2018 - 2022 ($ billion)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 IV - Market size and forecast 2023-2028
o Exhibit 34: Chart on IV - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on IV - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on IV - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on IV - Year-over-year growth 2023-2028 (%)
o 6.4 Oral - Market size and forecast 2023-2028
o Exhibit 38: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Type ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacy - Market size and forecast 2023-2028
o Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacy - Market size and forecast 2023-2028
o Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacy - Market size and forecast 2023-2028
o Exhibit 56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ billion)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Akebia Therapeutics Inc.
o Exhibit 111: Akebia Therapeutics Inc. - Overview
o Exhibit 112: Akebia Therapeutics Inc. - Product / Service
o Exhibit 113: Akebia Therapeutics Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 114: Amgen Inc. - Overview
o Exhibit 115: Amgen Inc. - Product / Service
o Exhibit 116: Amgen Inc. - Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 117: AstraZeneca Plc - Overview
o Exhibit 118: AstraZeneca Plc - Product / Service
o Exhibit 119: AstraZeneca Plc - Key news
o Exhibit 120: AstraZeneca Plc - Key offerings
o 12.6 Bayer AG
o Exhibit 121: Bayer AG - Overview
o Exhibit 122: Bayer AG - Business segments
o Exhibit 123: Bayer AG - Key news
o Exhibit 124: Bayer AG - Key offerings
o Exhibit 125: Bayer AG - Segment focus
o 12.7 Covis Pharma GmbH
o Exhibit 126: Covis Pharma GmbH - Overview
o Exhibit 127: Covis Pharma GmbH - Product / Service
o Exhibit 128: Covis Pharma GmbH - Key offerings
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 133: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 GlaxoSmithKline Plc
o Exhibit 142: GlaxoSmithKline Plc - Overview
o Exhibit 143: GlaxoSmithKline Plc - Business segments
o Exhibit 144: GlaxoSmithKline Plc - Key news
o Exhibit 145: GlaxoSmithKline Plc - Key offerings
o Exhibit 146: GlaxoSmithKline Plc - Segment focus
o 12.12 Japan Tobacco Inc.
o Exhibit 147: Japan Tobacco Inc. - Overview
o Exhibit 148: Japan Tobacco Inc. - Business segments
o Exhibit 149: Japan Tobacco Inc. - Key news
o Exhibit 150: Japan Tobacco Inc. - Key offerings
o Exhibit 151: Japan Tobacco Inc. - Segment focus
o 12.13 JCR Pharmaceticals Co. Ltd.
o Exhibit 152: JCR Pharmaceticals Co. Ltd. - Overview
o Exhibit 153: JCR Pharmaceticals Co. Ltd. - Product / Service
o Exhibit 154: JCR Pharmaceticals Co. Ltd. - Key offerings
o 12.14 Kirin Holdings Co. Ltd.
o Exhibit 155: Kirin Holdings Co. Ltd. - Overview
o Exhibit 156: Kirin Holdings Co. Ltd. - Business segments
o Exhibit 157: Kirin Holdings Co. Ltd. - Key offerings
o Exhibit 158: Kirin Holdings Co. Ltd. - Segment focus
o 12.15 Mitsubishi Chemical Group Corp.
o Exhibit 159: Mitsubishi Chemical Group Corp. - Overview
o Exhibit 160: Mitsubishi Chemical Group Corp. - Business segments
o Exhibit 161: Mitsubishi Chemical Group Corp. - Key offerings
o Exhibit 162: Mitsubishi Chemical Group Corp. - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 163: Pfizer Inc. - Overview
o Exhibit 164: Pfizer Inc. - Product / Service
o Exhibit 165: Pfizer Inc. - Key news
o Exhibit 166: Pfizer Inc. - Key offerings
o 12.17 Sun Pharmaceutical Industries Ltd.
o Exhibit 167: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 168: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 169: Sun Pharmaceutical Industries Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global renal anemia therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on IV - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on IV - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on IV - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on IV - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Distribution Channel ($ billion)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Akebia Therapeutics Inc. - Overview
Exhibits112: Akebia Therapeutics Inc. - Product / Service
Exhibits113: Akebia Therapeutics Inc. - Key offerings
Exhibits114: Amgen Inc. - Overview
Exhibits115: Amgen Inc. - Product / Service
Exhibits116: Amgen Inc. - Key offerings
Exhibits117: AstraZeneca Plc - Overview
Exhibits118: AstraZeneca Plc - Product / Service
Exhibits119: AstraZeneca Plc - Key news
Exhibits120: AstraZeneca Plc - Key offerings
Exhibits121: Bayer AG - Overview
Exhibits122: Bayer AG - Business segments
Exhibits123: Bayer AG - Key news
Exhibits124: Bayer AG - Key offerings
Exhibits125: Bayer AG - Segment focus
Exhibits126: Covis Pharma GmbH - Overview
Exhibits127: Covis Pharma GmbH - Product / Service
Exhibits128: Covis Pharma GmbH - Key offerings
Exhibits129: Daiichi Sankyo Co. Ltd. - Overview
Exhibits130: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits131: Daiichi Sankyo Co. Ltd. - Key news
Exhibits132: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits133: Dr Reddys Laboratories Ltd. - Overview
Exhibits134: Dr Reddys Laboratories Ltd. - Business segments
Exhibits135: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits136: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits137: F. Hoffmann La Roche Ltd. - Overview
Exhibits138: F. Hoffmann La Roche Ltd. - Business segments
Exhibits139: F. Hoffmann La Roche Ltd. - Key news
Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits142: GlaxoSmithKline Plc - Overview
Exhibits143: GlaxoSmithKline Plc - Business segments
Exhibits144: GlaxoSmithKline Plc - Key news
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Japan Tobacco Inc. - Overview
Exhibits148: Japan Tobacco Inc. - Business segments
Exhibits149: Japan Tobacco Inc. - Key news
Exhibits150: Japan Tobacco Inc. - Key offerings
Exhibits151: Japan Tobacco Inc. - Segment focus
Exhibits152: JCR Pharmaceticals Co. Ltd. - Overview
Exhibits153: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibits154: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibits155: Kirin Holdings Co. Ltd. - Overview
Exhibits156: Kirin Holdings Co. Ltd. - Business segments
Exhibits157: Kirin Holdings Co. Ltd. - Key offerings
Exhibits158: Kirin Holdings Co. Ltd. - Segment focus
Exhibits159: Mitsubishi Chemical Group Corp. - Overview
Exhibits160: Mitsubishi Chemical Group Corp. - Business segments
Exhibits161: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits162: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits168: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits169: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations